Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients.
Pediatr Radiol
; 49(4): 448-457, 2019 04.
Article
in En
| MEDLINE
| ID: mdl-30923876
ABSTRACT
Gadolinium has been used as a base for contrast agents in MRI for the last three decades. Numerous studies over the last 4 years have reported increased signal intensity in deep brain nuclei in non-contrast MRI images following gadolinium-based contrast agent (GBCA) administration. Pathology studies performed on adults and children, and rodent necropsy studies have also shown gadolinium deposition in brain and other tissues after GBCA administration. The purpose of this review was to summarize and discuss the knowledge gained from these reports and the relevance for imaging pediatric patients.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain
/
Magnetic Resonance Imaging
/
Contrast Media
/
Gadolinium
Limits:
Child
/
Humans
Language:
En
Journal:
Pediatr Radiol
Year:
2019
Document type:
Article
Affiliation country:
United States